Physician profile
Robert B Hauss
NPI 1972965481
$745.89
in general payments reported to CMS, 2019-2025
9 companies · $13.89 in 2025
The $13.89 reported for 2025 was less than what a typical Geriatric Medicine (Family Medicine) provider received nationally (typical 2025 total: $119).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $44.28 · 2021: $108 · 2022: $13.54 · 2023: $165 · 2024: $401 · 2025: $13.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $566 · Education: $13.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $565.74 |
| Education | $13.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $269.26 | 2021-2024 | Dexcom G6 Transmitter |
| Gilead Sciences, INC. | $149.57 | 2024 | Descovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.42 | 2024 | Jardiance |
| Novo Nordisk INC | $89.97 | 2020-2022 | |
| Glaxosmithkline, LLC. | $27.99 | 2024 | Arexvy, Bexsero, Shingrix |
| Insulet Corporation | $27.79 | 2021 | |
| Exact Sciences Corporation | $23.37 | 2024 | Cologuard Collection Kit |
| Abbott Laboratories | $19.63 | 2024 | Freestyle Libre 3 |
| Amgen INC. | $13.89 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Hauss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.